Top

Published in:

01-08-2020 | Positron Emission Tomography | Editorial

PET-derived bone information from 18F-sodium fluoride: A perfect match for whole-body PET/MR attenuation correction?

Authors: Martin Lyngby Lassen, PhD, Piotr J. Slomka, PhD

Published in: Journal of Nuclear Cardiology | Issue 4/2020

Excerpt

Following its introduction in 2011, the integrated positron emission tomography (PET)/MR (magnetic resonance imaging) systems received significant interest especially within the neurological societies because of the ideal combination of the superior soft-tissue contrast provided by MR and the functional information obtained from PET.1,2 Although the main application of hybrid PET/MR imaging to oncology and neurology studies,3 this hybrid modality is of keen interest to cardiology where its potential applications are considered strong for studies of cardiac inflammation, ischemic heart disease and ischemic cardiomyopathies as discussed in the joint position statement between the European Society of Cardiovascular Radiology (ESCR) and European Association of Nuclear Medicine (EANM).4 …

Delso G, Fürst S, Jakoby B, et al. Performance measurements of the siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52:1914–22.CrossRefPubMed

Beyer T, Lassen ML, Boellaard R, et al. Investigating the state-of-the-art in whole-body MR-based attenuation correction: An intra-individual, inter-system, inventory study on three clinical PET/MR systems. Magn Reson Mater Phys Biol Med. 2016;29:75–87. https://doi.org/10.1007/s10334-015-0505-4.CrossRef

Ehman EC, Johnson GB, Villanueva-Meyer JE, et al. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017. https://doi.org/10.1002/jmri.25711.CrossRefPubMedPubMedCentral

Nensa F, Bamberg F, Rischpler C, et al. Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM). Eur Radiol. 2018. https://doi.org/10.1007/s00330-017-5008-4.CrossRefPubMedPubMedCentral

Keller SH, Holm S, Hansen AE, et al. Image artifacts from MR-based attenuation correction in clinical, whole-body PET/MRI. Magn Reson Mater Phys Biol Med. 2013;26:173–81. https://doi.org/10.1007/s10334-012-0345-4.CrossRef

Lassen ML, Rasul S, Beitzke D, et al. Assessment of attenuation correction for myocardial PET imaging using combined PET/MRI. J Nucl Cardiol. 2017. https://doi.org/10.1007/s12350-017-1118-2.CrossRefPubMedPubMedCentral

Jones T, Townsend D. History and future technical innovation in positron emission tomography. J Med Imaging. 2017. https://doi.org/10.1117/1.JMI.4.1.011013.CrossRef

Martinez-Möller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: Evaluation with PET/CT data. J Nucl Med. 2009;50:520–6.CrossRefPubMed

Andersen FL, Ladefoged CN, Beyer T, et al. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone. Neuroimage. 2014;84:206–16.CrossRefPubMed

10.

Ladefoged CN, Law I, Anazodo U, et al. A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients. Neuroimage. 2016;147:346–59. https://doi.org/10.1016/j.neuroimage.2016.12.010.CrossRefPubMed

11.

Aznar MC, Sersar R, Saabye J, et al. Whole-body PET/MRI: The effect of bone attenuation during MR-based attenuation correction in oncology imaging. Eur J Radiol. 2014;83:1177–83.CrossRefPubMed

12.

Bezrukov I, Schmidt H, Mantlik F, et al. MR-based attenuation correction methods for improved PET quantification in lesions within bone and susceptibility artifact regions. J Nucl Med. 2013;54:1768–74. https://doi.org/10.2967/jnumed.112.113209.CrossRefPubMed

13.

Lau JMC, Laforest R, Sotoudeh H, et al. Evaluation of attenuation correction in cardiac PET using PET/MR. J Nucl Cardiol. 2015. https://doi.org/10.1007/s12350-015-0197-1.CrossRefPubMedPubMedCentral

14.

Vontobel J, Liga R, Possner M, et al. MR-based attenuation correction for cardiac FDG PET on a hybrid PET/MRI scanner: comparison with standard CT attenuation correction. Eur J Nucl Med Mol Imaging. 2015;42:1574–80. https://doi.org/10.1007/s00259-015-3089-3.CrossRefPubMed

15.

Queiroz MA, Huellner MW. PET/MR in cancers of the head and neck. Semin Nucl Med. 2015;45:248–65. https://doi.org/10.1053/j.semnuclmed.2014.12.005.CrossRefPubMed

16.

Joshi NV, Vesey AT, Williams MC, et al. ¹⁸F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet. 2014;383:705–13. https://doi.org/10.1016/S0140-6736(13)61754-7.CrossRefPubMed

17.

Kuttner S, Lassen ML, Øen SK, et al. Quantitative PET/MR imaging of lung cancer in the presence of artifacts in the MR-based attenuation correction maps. Acta Radiol. 2019. https://doi.org/10.1177/0284185119848118.CrossRefPubMed

18.

Schramm G, Maus J, Hofheinz F, et al. Correction of quantification errors in pelvic and spinal lesions caused by ignoring higher photon attenuation of bone in [¹⁸F]NaF PET/MR. Med Phys. 2015;42:6468–76. https://doi.org/10.1118/1.4932367.CrossRefPubMed

19.

Dweck MR, Chow MW, Joshi NV, et al. Coronary arterial ¹⁸F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59:1539–48. https://doi.org/10.1016/j.jacc.2011.12.037.CrossRefPubMed

20.

Jenkins WSA, Vesey AT, Shah ASV, et al. Valvular ¹⁸F-fluoride and ¹⁸F-fluorodeoxyglucose uptake predict disease progression and clinical outcome in patients with aortic stenosis. J Am Coll Cardiol. 2015;66:1200–1. https://doi.org/10.1016/j.jacc.2015.06.1325.CrossRefPubMed

21.

Cal-Gonzalez J, Li X, Heber D, et al. Partial volume correction for improved PET quantification in ¹⁸F-NaF imaging of atherosclerotic plaques. J Nucl Cardiol C. 2017. https://doi.org/10.1007/s12350-017-0778-2.CrossRef

22.

Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone ¹⁸F-NaF deposition. J Nucl Med. 2010;51:1826–9. https://doi.org/10.2967/jnumed.110.077933.CrossRefPubMed

23.

Schirrmeister H, Glatting G, Hetzel J, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and ¹⁸F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001;42:1800–4.PubMed

24.

Karakatsanis NA, Abgral R, Trivieri MG, et al. Hybrid PET- and MR-driven attenuation quantification in cardiovascular PET/MR imaging. J Nucl Cardiol. 2019. https://doi.org/10.1007/s12350-019-01928-0.CrossRefPubMedPubMedCentral

25.

Ouyang J, Chun SY, Petibon Y, et al. Bias atlases for segmentation-based PET attenuation correction using PET-CT and MR. IEEE Trans Nucl Sci. 2013;60:3373–82.CrossRefPubMedPubMedCentral

26.

Wong KK, Piert M. Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: Mechanisms and applications. J Nucl Med. 2013;54:590–9. https://doi.org/10.2967/jnumed.112.114298.CrossRefPubMed

27.

Kaster TS, Dwivedi G, Susser L, et al. Single low-dose CT scan optimized for rest-stress PET attenuation correction and quantification of coronary artery calcium. J Nucl Cardiol. 2015;22:419–28. https://doi.org/10.1007/s12350-014-0026-y.CrossRefPubMed

Title: PET-derived bone information from 18F-sodium fluoride: A perfect match for whole-body PET/MR attenuation correction?
Authors: Martin Lyngby Lassen, PhD
Piotr J. Slomka, PhD
Publication date: 01-08-2020
Publisher: Springer International Publishing
Keyword: Positron Emission Tomography
Published in: Journal of Nuclear Cardiology / Issue 4/2020
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-019-01994-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

PET-derived bone information from 18F-sodium fluoride: A perfect match for whole-body PET/MR attenuation correction?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2020

Correction to: Aortic valve and coronary 18F-sodium fluoride activity: a common cause?

When you are the first-in-the-country fellow in a fellowship program that is as unheard of as the disease itself: cardiac amyloidosis fellowship

Cardiac uptake patterns in routine 18F-FDG PET-CT scans: A pictorial review

Correction to: Staged testing as a solution to the challenges of testing lower risk patients

Fractional flow reserve as the standard of reference: All that glistens is not gold

A quick glance at selected topics in this issue

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page